Nektar Therapeutics (NKTR)
73.49
-2.46
(-3.24%)
USD |
NASDAQ |
May 14, 15:05
Nektar Therapeutics Free Cash Flow : -203.94M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| Aquestive Therapeutics, Inc. | -52.99M |
| Boston Scientific Corp. | 3.475B |
| Esperion Therapeutics, Inc. | -10.88M |
| Corcept Therapeutics, Inc. | 119.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -44.30M |
| Cash from Investing (Quarterly) | -350.79M |
| Cash from Financing (Quarterly) | 529.55M |
| Free Cash Flow Per Share (Quarterly) | -1.792 |
| Free Cash Flow to Equity (Quarterly) | -38.84M |
| Free Cash Flow to Firm (Quarterly) | -36.36M |
| Free Cash Flow Yield | -14.22% |